Ligand Pharmaceuticals Inc (LGND)
87.12
+1.00
(+1.16%)
USD |
NASDAQ |
May 10, 16:00
87.12
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Revenue (Annual): 131.31M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 131.31M |
| December 31, 2022 | 196.24M |
| December 31, 2021 | 241.54M |
| December 31, 2020 | 163.56M |
| December 31, 2019 | 120.28M |
| December 31, 2018 | 251.45M |
| December 31, 2017 | 141.10M |
| December 31, 2016 | 108.97M |
| December 31, 2015 | 71.91M |
| December 31, 2014 | 64.54M |
| December 31, 2013 | 48.97M |
| December 31, 2012 | 31.39M |
| December 31, 2011 | 30.04M |
| December 31, 2010 | 23.54M |
| December 31, 2009 | 38.94M |
| Date | Value |
|---|---|
| December 31, 2008 | 27.32M |
| December 31, 2007 | 12.89M |
| December 31, 2006 | 3.977M |
| December 31, 2005 | 10.22M |
| December 31, 2004 | 112.11M |
| December 31, 2003 | 81.12M |
| December 31, 2002 | 71.77M |
| December 31, 2001 | 76.34M |
| December 31, 2000 | 48.11M |
| December 31, 1999 | 40.90M |
| December 31, 1998 | 17.70M |
| December 31, 1997 | 51.70M |
| December 31, 1996 | 36.80M |
| December 31, 1995 | 24.50M |
| December 31, 1994 | 13.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
120.28M
Minimum
2019
241.54M
Maximum
2021
170.59M
Average
163.56M
Median
2020
Revenue (Annual) Benchmarks
| ANI Pharmaceuticals Inc | 486.82M |
| ADMA Biologics Inc | 258.22M |
| Viking Therapeutics Inc | -- |
| Voyager Therapeutics Inc | 250.01M |
| Palatin Technologies Inc | 4.854M |